![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LINC01541 |
Gene summary for LINC01541 |
![]() |
Gene information | Species | Human | Gene symbol | LINC01541 | Gene ID | 100505776 |
Gene name | long intergenic non-protein coding RNA 1541 | |
Gene Alias | UTAT39 | |
Cytomap | 18q22.3 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100505776 | LINC01541 | EEC-subject3 | Human | Endometrium | EEC | 1.00e-16 | -4.26e-01 | -0.2525 |
100505776 | LINC01541 | EEC-subject5 | Human | Endometrium | EEC | 6.26e-04 | -3.07e-01 | -0.249 |
100505776 | LINC01541 | GSM5276934 | Human | Endometrium | EEC | 4.55e-20 | -5.21e-01 | -0.0913 |
100505776 | LINC01541 | GSM5276935 | Human | Endometrium | EEC | 2.35e-08 | -3.50e-01 | -0.123 |
100505776 | LINC01541 | GSM5276937 | Human | Endometrium | EEC | 6.98e-06 | -4.14e-01 | -0.0897 |
100505776 | LINC01541 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 1.58e-16 | -5.43e-01 | -0.1869 |
100505776 | LINC01541 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 1.37e-14 | -5.43e-01 | -0.1875 |
100505776 | LINC01541 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 3.77e-17 | -5.43e-01 | -0.1883 |
100505776 | LINC01541 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 1.17e-28 | -5.43e-01 | -0.1934 |
100505776 | LINC01541 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 1.17e-28 | -5.43e-01 | -0.1917 |
100505776 | LINC01541 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.68e-22 | -5.43e-01 | -0.1916 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Endometrium | ![]() | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |